James C. H. Chow

Consolidative Radiotherapy After Gemcitabine‐Platinum Chemotherapy in De Novo Metastatic Nasopharyngeal Carcinoma: Impact of Chemotherapy Backbone and Prognostic Factors on Survival

ABSTRACT Introduction De novo metastatic nasopharyngeal carcinoma (NPC) has a poor prognosis despite modern chemotherapy. Gemcitabine‐cisplatin is the standard chemotherapy backbone, whereas carboplatin is commonly used as a cisplatin alternative for its better tolerability. This...